Consumer health giant Johnson & Johnson said Friday it is “responding to inquiries” from the DOJ and SEC about the Foreign Corrupt Practices Act.… Continue Reading
A former saleswoman for medical device maker Acclarent was awarded $3.5 million as her share of an $18 million settlement of a whistleblower suit alleging false marketing claims.
Melayna Lokosky made the claims in a complaint filed in federal court in Massachusetts in 2011.… Continue Reading
A plaintiffs law firm that specializes in securities class action litigation was ordered to pay sanctions to Boeing over a lawsuit the firm pressed even though the crucial witness behind it didn’t know anything relevant.… Continue Reading
Reporting companies filed Form SDs with the SEC Monday, and most said its not fully clear if their products contain conflict minerals from Africa’s Congo region.
Tuesday’s print edition of the Wall Street Journal said nearly 1,300 U.S.-listed… Continue Reading
GlaxoSmithKline (GSK) will not be paying doctors to promote its pharmaceutical products through speeches following a corruption scandal in China that was disclosed earlier this year. It will also not make its sales force have individual sales targets any longer.… Continue Reading
The FCPA Blog wanted to explore the idea of the dual-hatted compliance officer — the one who occupies both the general counsel and chief compliance officer roles in a company. We talked with the former SEC Chairman and now Kalorama Partners CEO, Harvey Pitt.… Continue Reading
Health care giant Johnson & Johnson will pay more than $2.2 billion to resolve criminal and civil claims arising from allegations of kickbacks to U.S. doctors and improper marketing claims about three of its prescription drugs.… Continue Reading